Loomis Sayles & Co. L P Lowers Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Loomis Sayles & Co. L P lessened its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.3% in the 4th quarter, Holdings Channel.com reports. The firm owned 1,724,281 shares of the medical equipment provider’s stock after selling 59,042 shares during the quarter. Intuitive Surgical comprises about 97.2% of Loomis Sayles & Co. L P’s holdings, making the stock its 19th biggest position. Loomis Sayles & Co. L P’s holdings in Intuitive Surgical were worth $900,006,000 as of its most recent SEC filing.

A number of other large investors also recently bought and sold shares of ISRG. Howard Capital Management Group LLC raised its position in Intuitive Surgical by 4.5% during the third quarter. Howard Capital Management Group LLC now owns 2,125 shares of the medical equipment provider’s stock worth $1,044,000 after acquiring an additional 92 shares during the period. Principal Financial Group Inc. raised its position in shares of Intuitive Surgical by 1.5% during the 3rd quarter. Principal Financial Group Inc. now owns 602,393 shares of the medical equipment provider’s stock worth $295,938,000 after purchasing an additional 9,194 shares during the last quarter. Quest Partners LLC acquired a new position in shares of Intuitive Surgical during the 3rd quarter worth about $173,000. Algert Global LLC acquired a new stake in Intuitive Surgical in the 3rd quarter worth about $1,988,000. Finally, Larson Financial Group LLC increased its stake in Intuitive Surgical by 79.4% during the 3rd quarter. Larson Financial Group LLC now owns 854 shares of the medical equipment provider’s stock worth $420,000 after buying an additional 378 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Buying and Selling at Intuitive Surgical

In related news, Director Amal M. Johnson sold 4,635 shares of the business’s stock in a transaction on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total value of $2,626,191.00. Following the sale, the director now owns 12,275 shares in the company, valued at approximately $6,955,015. The trade was a 27.41 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Robert Desantis sold 11,545 shares of the firm’s stock in a transaction dated Thursday, March 13th. The shares were sold at an average price of $499.22, for a total value of $5,763,494.90. Following the transaction, the executive vice president now owns 5,224 shares of the company’s stock, valued at $2,607,925.28. This trade represents a 68.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 33,754 shares of company stock valued at $17,691,621 over the last quarter. 0.90% of the stock is owned by company insiders.

Intuitive Surgical Price Performance

Shares of ISRG opened at $509.03 on Thursday. The firm has a 50-day simple moving average of $559.82 and a two-hundred day simple moving average of $532.42. Intuitive Surgical, Inc. has a 1-year low of $364.17 and a 1-year high of $616.00. The stock has a market cap of $181.31 billion, a PE ratio of 79.41, a P/E/G ratio of 5.85 and a beta of 1.43.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on ISRG. Erste Group Bank lowered Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research note on Monday, March 17th. Royal Bank of Canada upped their target price on shares of Intuitive Surgical from $611.00 to $641.00 in a report on Monday, January 27th. Morgan Stanley raised shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and raised their price target for the stock from $522.00 to $650.00 in a research note on Monday, December 2nd. Robert W. Baird dropped their price objective on shares of Intuitive Surgical from $707.00 to $600.00 and set an “outperform” rating for the company in a research note on Tuesday, March 18th. Finally, Wells Fargo & Company raised their target price on shares of Intuitive Surgical from $630.00 to $687.00 and gave the stock an “overweight” rating in a research note on Friday, January 24th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have given a buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $611.86.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.